Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Chambers

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2010
Does Medicare have an implicit cost-effectiveness threshold?James D Chambers, Peter J Neumann, Martin J Buxton
Clinical Therapeutics|July 22, 2024
Balancing Evidence and Need: Variation in US Commercial Payer Coverage of EsketamineEkwu B Ochigbo, Molly T Beinfeld, James D Chambers
The American Journal of Managed Care|August 20, 2016
The impact of formulary drug exclusion policies on patients and healthcare costsJames D Chambers, Pallavi B Rane, Peter J Neumann
The American Journal of Managed Care|September 24, 2016
Mapping US commercial payers' coverage policies for medical interventionsJames D Chambers, Matthew D Chenoweth, Peter J Neumann
Health Affairs (Project Hope)|April 12, 2012
Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countriesPeter J Neumann, Sarah K Bliss, James D Chambers
Journal of Managed Care & Specialty Pharmacy|November 24, 2021
Use of prescriber requirements among US commercial health plansKelly Lenahan, Ari D Panzer, Rebecca Gertler, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 13, 2015
The lag from FDA approval to published cost-utility evidenceJames D Chambers, Teja Thorat, Junhee Pyo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2023
Variation in Medicaid and commercial payer coverage of aducanumab for Alzheimer's diseasePei-Jung Lin, Adele Levine, Julia Rucker, et al.
Journal of Vascular Surgery|August 3, 2012
Cost-effectiveness in the contemporary management of critical limb ischemia with tissue lossNeal R Barshes, James D Chambers, Joshua Cohen, et al.
Journal of Managed Care & Specialty Pharmacy|April 3, 2025
Assessing variation in US payer coverage of anti-vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edemaJames D Chambers, Molly T Beinfeld, Terry Richardson, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 17, 2010
Does Medicare have an implicit cost-effectiveness threshold?James D Chambers, Peter J Neumann, Martin J Buxton
Clinical Therapeutics|July 22, 2024
Balancing Evidence and Need: Variation in US Commercial Payer Coverage of EsketamineEkwu B Ochigbo, Molly T Beinfeld, James D Chambers
The American Journal of Managed Care|August 20, 2016
The impact of formulary drug exclusion policies on patients and healthcare costsJames D Chambers, Pallavi B Rane, Peter J Neumann
The American Journal of Managed Care|September 24, 2016
Mapping US commercial payers' coverage policies for medical interventionsJames D Chambers, Matthew D Chenoweth, Peter J Neumann
Health Affairs (Project Hope)|April 12, 2012
Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countriesPeter J Neumann, Sarah K Bliss, James D Chambers
Journal of Managed Care & Specialty Pharmacy|November 24, 2021
Use of prescriber requirements among US commercial health plansKelly Lenahan, Ari D Panzer, Rebecca Gertler, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|January 13, 2015
The lag from FDA approval to published cost-utility evidenceJames D Chambers, Teja Thorat, Junhee Pyo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 28, 2023
Variation in Medicaid and commercial payer coverage of aducanumab for Alzheimer's diseasePei-Jung Lin, Adele Levine, Julia Rucker, et al.
Journal of Vascular Surgery|August 3, 2012
Cost-effectiveness in the contemporary management of critical limb ischemia with tissue lossNeal R Barshes, James D Chambers, Joshua Cohen, et al.
Journal of Managed Care & Specialty Pharmacy|April 3, 2025
Assessing variation in US payer coverage of anti-vascular endothelial growth factor therapies for the treatment of age-related macular degeneration, diabetic retinopathy, and diabetic macular edemaJames D Chambers, Molly T Beinfeld, Terry Richardson, et al.
Pageof 10